Buparvaquone is a second-generation hydroxynaphtaquinone with novel features that make it an effective compound for the therapy and prophylaxis of all forms of theileriosis.

Indications

For treatment of tick-transmitted theileriosis caused by the intracellular protozoan parasites Theileria parva (East Coast fever, Corridor disease, Zimbabwean theileriosis) and T. annulata (tropical theileriosis) in cattle. It is active against both the schizont and piroplasm stages of Theileria spp. and may be used during the incubation period of the disease, or when clinical signs are apparent.

Contra-indications

Due to the inhibiting effects of theileriosis on the immune system, vaccination should be delayed until the animal has recovered from theileriosis.

Side Effects

Localised, painless, oedematous swelling may occasionally be seen at the injection site.

Administration and Dosage

For intramuscular injection.

The general dosage is 1 ml per 20 kg body weight.

In severe cases the treatment may be repeated within 48 – 72 hours. Do not administer more than 10 ml per injection site. Successive injections should be administered at different sites.

Withdrawal Times

- For meat : 42 days.

- For milk : 2 day

Storage

Store below 25ºC, in a cool and dry place, and protect from light.

For Veterinary UseOnly , Keep out of reach of children